Tetsuo Shimizu
- Biochemistry top 5%
- Blood transfusion and management 8
-
- Blood donation and transfusion practices 6
- Hematology top 10%
-
- Lung Cancer Treatments and Mutations 18
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 8
- Medical Imaging and Pathology Studies 5
-
- Lung Cancer Research Studies 13
- Cancer Immunotherapy and Biomarkers 6
-
- Neuroendocrine Tumor Research Advances 10
In The Last Decade
Tetsuo Shimizu
87 papers receiving 935 citations
Peers
Comparison fields: 5 of 112
- Biochemistry 129
- Management of Technology and Innovation 77
- Hematology 115
- Pulmonary and Respiratory Medicine 293
- Cancer Research 115
Countries citing papers authored by Tetsuo Shimizu
This map shows the geographic impact of Tetsuo Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Shimizu more than expected).
Fields of papers citing papers by Tetsuo Shimizu
This network shows the impact of papers produced by Tetsuo Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Shimizu. The network helps show where Tetsuo Shimizu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tetsuo Shimizu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2021 | 1 | |
| 8 | 2019 | 6 | |
| 9 | 2018 | 48 | |
| 10 | End of life care for lung cancer patients | 2014 | 1 |
| 11 | 2003 | 46 | |
| 12 | The Diagnostic Value of Bronchial Arteriography for Hemoptysis | 2002 | 1 |
| 13 | 2001 | 2 | |
| 14 | 2000 | 4 | |
| 15 | 1999 | 1 | |
| 16 | 1993 | 73 | |
| 17 | 1992 | 22 | |
| 18 | 1990 | 1 | |
| 19 | 1982 | 3 | |
| 20 | 1965 | 9 |
About Tetsuo Shimizu
Tetsuo Shimizu is a scholar working on Biochemistry, Pulmonary and Respiratory Medicine and Oncology, having authored 95 papers that have together received 968 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (13 papers), Neuroendocrine Tumor Research Advances (10 papers), Blood transfusion and management (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Blood donation and transfusion practices (6 papers) and Medical Imaging and Pathology Studies (5 papers). The work is most often cited by research in Biochemistry (129 citations), Management of Technology and Innovation (77 citations) and Hematology (115 citations). Tetsuo Shimizu has collaborated with scholars based in Japan, Germany and Australia. Frequent co-authors include S Murphy, Yasuhiro Gon, Shuichiro Maruoka, Kenji Mizumura, Shu Hashimoto, Noriaki Takahashi, Mari Hikichi, Yoshiko Nakagawa, Yuko Iida and Yoko Nakanishi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.